Ligand Pharmaceuticals reported $45.74M in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acceleron Pharma XLRN:US $ -63.6M 6.01M
Acorda Therapeutics ACOR:US $ -28.78M 49.61M
Agenus AGEN:US $ -41.37M 19.66M
Amgen AMGN:US $ 828M 1301M
Anika Therapeutics ANIK:US $ 1.26M 19.21M
Arena Pharmaceuticals ARNA:US $ -131.99M 9.65M
Arrowhead Research ARWR:US $ -28232000 4.18M
Baxter International BAX:US $ 424M 34M
Bristol Myers Squibb BMY:US $ 1715M 36M
Clovis Oncology CLVS:US $ -57.58M 0.43M
Dicerna Pharmaceuticals DRNA:US $ -29.11M 2.54M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Enanta Pharmaceuticals ENTA:US $ -29.7M 17.4M
Endo International Ordinary Shares ENDP:US $ 182.68M 51.82M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
Glaxosmithkline GSK:US $ 1675M 18M
Harsco HSC:US $ 36.17M 16.6M
Heron Therapeutics HRTX:US $ -52.11M 9.18M
Immunogen IMGN:US $ -27.37M 1.55M
Insmed INSM:US $ -83833000 10.7M
Intrexon XON:US $ -17.69M 21.23M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Karyopharm Therapeutics KPTI:US $ -52373000 15.31M
Lannett LCI:US $ 2.85M 219.45M
Ligand Pharmaceuticals LGND:US $ 45.74M 45.82M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 1497M 1517M
Pacira Pharmaceuticals PCRX:US $ 34.84M 15.41M
Pfizer PFE:US $ 5914M 397M
Rigel Pharmaceuticals RIGL:US $ -13.05M 54.8M
Sangamo Biosciences SGMO:US $ -46.3M 2.87M
Spectrum Pharmaceuticals SPPI:US $ -33.69M 29.2M
Teva Pharmaceutical Industries TEVA:US $ 582M 148M
Veracyte VCYT:US $ -7.47M 37.94M